INTERNATIONAL PATENT: BIOPHYTIS FILES APPLICATION FOR "PHYTOECDYSONES AND/OR 20-HYDROXYECDYSONE DERIVATIVES IN COMBINATION WITH A GLP-1 AGONIST FOR USE THEREOF IN THE TREATMENT OF OBESITY AND EXCESS WEIGHT"

GENEVA, Aug. 11 -- BIOPHYTIS (14 Avenue de l'Opera75001 PARIS) filed a patent application (PCT/EP2025/052555) for "PHYTOECDYSONES AND/OR 20-HYDROXYECDYSONE DERIVATIVES IN COMBINATION WITH A GLP-1 AGONIST FOR USE THEREOF IN THE TREATMENT OF OBESITY AND EXCESS WEIGHT" on Jan 31, 2025. With publication no. WO/2025/163156, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DILDA, Pierre (19 Avenue de Versailles75016 PARIS), LATIL, Mathilde (71 Quai de la Seine75019 PARIS), LAFONT, Rene (30 Rue Claude Lorrain75016 PARIS), VEILLET...